| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 733906 | Null | 0.0147237897640499 | -0.1163775 |
| NSC 734562 | 6-(3-Aminopropyl)-9-bromo-5,6-dihydro-3-nitro-5,11-dioxo-11H -indeno[1,2-c]isoquinoline Hydrochloride | 0.0147237897640499 | 0.13341559 |
| NSC 736164 | pyrazoline derivative | 0.0147237897640499 | 0.17186065 |
| NSC 757949 | (1R,2E,6R,10E,11aS,13S,14aR)-6-(2-(benzyloxy)ethyl)-1,13-dihydroxy-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one | 0.0147237897640499 | 0.080516479 |
| NSC 679001 | 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- | 0.0164116791870034 | 0.070053889 |
| NSC 682763 | Null | 0.0164116791870034 | 0.087778629 |
| NSC 690270 | ANTINEOPLASTIC-690270 | 0.0164116791870034 | 0.050105492 |
| NSC 695941 | 6H-Imidazo[4,5,1-de]acridin-6-one, 5-[3-[[3-[[5-nitro-1,3-dioxo- 2H-benz[de]isoquinolin- 2-yl]propyl](methyl)amino]propyl]amino]-, dimethanesulfonate | 0.0164116791870034 | 0.12742113 |
| NSC 698058 | Null | 0.0164116791870034 | 0.1111769 |
| NSC 703092 | Null | 0.0164116791870034 | 0.21095133 |